Thursday 25th, well it wil be interesting. CU6 probably a better guide to gauge an idea rather than TLX in terms of progression but when you look at market caps/EV there is plenty of room for RAD to move. Management is impressive with the recent new appointment Riccardo Canevari to be CEO who came from Novartis. From a recent article:
There has been an extreme level of investor interest in the radiopharmaceutical sector in recent years and significant M&A activity globally including within the key market of China. Several key transactions have led to this activity including the Novartis acquisition of Advanced Accelerator Applications and Endocyte for $3.9 billion and $2.1 billion respectively.
- Forums
- IPOs
- RadioPharm Theranostics
RadioPharm Theranostics, page-92
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online